BAFFling Autoimmune Disorders and Helicobacter pylori Disease: The Interplay between BAFF and the Th17 Response

ISSN： 2212-7070

Source： Clinical Immunology, Endocrine & Metabolic Drugs, Vol.2, Iss.1, 2015-06, pp. : 4-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

BAFF: B cell survival factor and emerging therapeutic target for autoimmune disorders

By Kalled Susan L Ambrose Christine Hsu Yen-Ming

Expert Opinion on Therapeutic Targets, Vol. 7, Iss. 1, 2003-02 ,pp. : 115-123

Informa Healthcare

Access to resources Recommend Favorite

Helicobacter Pylori Infection, Immune Response and Vaccination

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 1, Iss. 3, 2001-11 ,pp. : 199-208

Bentham Science Publishers

Access to resources Recommend Favorite

A link between platelet to lymphocyte ratio and Helicobacter pylori infection

Journal Of Clinical Laboratory Analysis (Electronic), Vol. 32, Iss. 1, 2018-01 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clarithromycin for Helicobacter pylori infection

By Leung W.K. Graham D.Y.

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 3, 2000-03 ,pp. : 507-514

Informa Healthcare

Access to resources Recommend Favorite

Helicobacter pylori: strategies for treatment

By Gomollón Fernando Sicilia Beatriz

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 7, 2001-07 ,pp. : 1231-1241

Informa Healthcare

Access to resources Recommend Favorite